Cikkek nyilvánosan hozzáférhető megbízással - Luigi BuonaguroTovábbi információ
Sehol sem hozzáférhető: 10
Combinatorial immunotherapy strategies for hepatocellular carcinoma
M Tagliamonte, A Petrizzo, ML Tornesello, G Ciliberto, FM Buonaguro, ...
Current opinion in immunology 39, 103-113, 2016
Megbízások: Government of Italy
Cellular prognostic markers in hepatocellular carcinoma
L Buonaguro, M Tagliamonte, A Petrizzo, E Damiano, ML Tornesello, ...
Future Oncology 11 (11), 1591-1598, 2015
Megbízások: Government of Italy
Microorganisms-derived antigens for preventive anti-cancer vaccines
L Buonaguro, B Cavalluzzo, A Mauriello, C Ragone, AL Tornesello, ...
Molecular Aspects of Medicine 92, 101192, 2023
Megbízások: Government of Italy
Cancer vaccines for hepatocellular carcinoma: future directions
FM Buonaguro, L Buonaguro
Immunotherapy 8 (4), 391-393, 2016
Megbízások: Government of Italy
Systems vaccinology for cancer vaccine development
A Petrizzo, M Tagliamonte, M Tornesello, FM Buonaguro, L Buonaguro
Expert Review of Vaccines 13 (6), 711-719, 2014
Megbízások: Government of Italy
Assessment of Chlamydia trachomatis infection among Eastern European and West African women immigrants in South Italy
ML Tornesello, N De Rosa, F Sarappa, L Buonaguro, R Piccoli, ...
Sexually transmitted infections 88 (1), 70-71, 2012
Megbízások: US National Institutes of Health
Profiling the HCV Immune Response in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma by Peptide Microarray Analysis
AL Tornesello, U Reimer, P Holenya, T Knaute, F Pezzuto, F Izzo, ...
Current Medicinal Chemistry 29 (15), 2736-2747, 2022
Megbízások: Government of Italy
B-105 Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine-HEPAVAC
L Buonaguro
JAIDS Journal of Acquired Immune Deficiency Syndromes 77, 37, 2018
Megbízások: US National Institutes of Health
A-108 Viral and cellular biomarkers in HPV-related cancers
F Buonaguro, C Annunziata, L Buonaguro, ML Tornesello
JAIDS Journal of Acquired Immune Deficiency Syndromes 71, 37, 2016
Megbízások: US National Institutes of Health
F-104 Hepatitis virus associated liver cancer: Pathogenesis and immunotherapeutic strategies
F Buonaguro, C Annunziata, L Buonaguro, ML Tornesello
JAIDS Journal of Acquired Immune Deficiency Syndromes 71, 61, 2016
Megbízások: US National Institutes of Health
Valahol hozzáférhető: 88
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ...
The Lancet infectious diseases 19 (2), 143-155, 2019
Megbízások: UK Medical Research Council
Antimicrobial peptides as anticancer agents: functional properties and biological activities
AL Tornesello, A Borrelli, L Buonaguro, FM Buonaguro, ML Tornesello
Molecules 25 (12), 2850, 2020
Megbízások: Government of Italy
Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies
F Pezzuto, L Buonaguro, F Caponigro, F Ionna, N Starita, C Annunziata, ...
Oncology 89 (3), 125-136, 2015
Megbízások: Government of Italy
The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer
ML Tornesello, R Faraonio, L Buonaguro, C Annunziata, N Starita, ...
Frontiers in oncology 10, 150, 2020
Megbízások: Government of Italy
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro
Genomics 102 (2), 74-83, 2013
Megbízások: Government of Italy
Antigen-specific vaccines for cancer treatment
M Tagliamonte, A Petrizzo, ML Tornesello, FM Buonaguro, L Buonaguro
Human vaccines & immunotherapeutics 10 (11), 3332-3346, 2014
Megbízások: Government of Italy
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
MW Löffler, C Mohr, L Bichmann, LK Freudenmann, M Walzer, ...
Genome medicine 11, 1-16, 2019
Megbízások: German Research Foundation, National Institute for Health Research, UK …
Selecting target antigens for cancer vaccine development
L Buonaguro, M Tagliamonte
Vaccines 8 (4), 615, 2020
Megbízások: European Commission
Challenges in cancer vaccine development for hepatocellular carcinoma
L Buonaguro, A Petrizzo, M Tagliamonte, ML Tornesello, FM Buonaguro
Journal of hepatology 59 (4), 897-903, 2013
Megbízások: Government of Italy
Immunogenomics and systems biology of vaccines
L Buonaguro, B Pulendran
Immunological reviews 239 (1), 197-208, 2011
Megbízások: US National Institutes of Health
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.